Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells

被引:22
|
作者
Xu, Bing [1 ]
Kitawaki, Jo [1 ]
Koshiba, Hisato [1 ]
Ishihara, Hiroaki [1 ]
Kiyomizu, Miyo [1 ]
Teramoto, Mariko [1 ]
Kitaoka, Yui [1 ]
Honjo, Hideo [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Obstet & Gynecol, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan
关键词
hormone replacement therapy; breast cancer cells; progestogen; estrogen-metabolizing enzyme;
D O I
10.1016/j.maturitas.2006.07.003
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: To investigate the in vitro effects of five progestogens commonly used in hormone replacement therapy (HRT) on estrogen-metabolizing enzymes in human breast cancer cells. Methods: The human hormone-dependent breast cancer cell lines T47D, MCF-7, and MCF-7aro were cultured with estradiol (E-2) and progestogens. The mRNA levels of estrogen-metabolizing enzymes were determined by RT-PCR or Northern blot, and enzyme activities by radiolabeled substrates. Cell proliferation was measured by bromodeoxyuridine incorporation. In vitro models for continuous combined regimen (CCR) and sequential combined regimen (SCR) were established to mimic the in vivo conditions of HRT. Results: Medroxyprogesterone acetate (MPA) plus E-2 (10(-8) M) stimulated the mRNA levels and activities of estrogen-activating enzymes aromatase (at 10(-8) M MPA), 17 beta-hydroxysteroid dehydrogenase type 1 (17 beta HSD1) (at 10(-6) M), and sulfatase (at 10(-8) to 10-6 M) compared to E2 only. Progesterone also stimulated enzyme activity, but to a lower magnitude. Levonorgestrel, norethindrone, and dienogest showed no enzyme stimulation. The estrogen-inactivating enzymes 17 beta-hydroxysteroid dehydrogenase type 2 and sulfotransferase were not affected by any of the progestogens tested. However, all the progestogens (at 10-8 to 10(-6) M) inhibited E-2-stimulated cell proliferation. While increased aromatase and 17 beta HSD1 activities were observed in the CCR model, no significant enzyme stimulation was observed in the SCR model. Conclusions: The present study suggested that progestogens exert different actions on estrogen-metabolizing enzymes in breast cancer cells dependent on the specific progestogen and regimen used. Further studies are needed to elucidate whether MPA, a progestogen currently used in HRT, leads to a higher risk of breast cancer development than other progestogens. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:142 / 152
页数:11
相关论文
共 50 条
  • [1] Estrogen-metabolizing enzymes in breast cancer cell lines
    LanisnikRizner, Tea
    Hevir, Neli
    Trost, Nina
    Debeljak, Natasa
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S45 - S45
  • [2] Estrogen-metabolizing enzymes and endometrial cancer
    Rizner, Tea Lanisnik
    Hevir, Neli
    Smuc, Tina
    Sinkovec, Jasna
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 : S21 - S21
  • [3] Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer
    Smuc, T
    Rupreht, R
    Sinkovec, J
    Adamski, J
    Rizner, TL
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 248 (1-2) : 114 - 117
  • [4] The role of estrogen-metabolizing enzymes and estrogen receptors in human epidermis
    Inoue, Takayoshi
    Miki, Yasuhiro
    Abe, Keiko
    Hatori, Masahito
    Hosaka, Masami
    Kariya, Yoshiyuki
    Kakuo, Shingo
    Fujimura, Tsutomu
    Hachiya, Akira
    Aiba, Setsuya
    Sasano, Hironobu
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2011, 344 (1-2) : 35 - 40
  • [5] Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes:: Clinical implications
    Kristensen, VN
    Sorlie, T
    Geisler, J
    Langerod, A
    Yoshimura, N
    Kåresen, R
    Harada, N
    Lonning, PE
    Borresen-Dale, AL
    CLINICAL CANCER RESEARCH, 2005, 11 (02) : 878S - 883S
  • [6] Estrogen receptors and estrogen-metabolizing enzymes in human ovaries during fetal development
    Vaskivuo, TE
    Mäentausta, M
    Törn, S
    Oduwole, O
    Lönnberg, A
    Herva, R
    Isomaa, V
    Tapanainen, JS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06): : 3752 - 3756
  • [7] Breast cancer and steroid metabolizing enzymes: The role of progestogens
    Pasqualini, Jorge R.
    MATURITAS, 2009, 65 : S17 - S21
  • [8] Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival
    Long, Ji-Rong
    Cai, Qiuyin
    Shu, Xiao-Ou
    Cai, Hui
    Gao, Yu-Tang
    Zheng, Wei
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (05): : 331 - 338
  • [9] A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis
    Modugno, F
    Knoll, C
    Kanbour-Shakir, A
    Romkes, M
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 (03) : 191 - 197
  • [10] A Potential Role for the Estrogen-metabolizing Cytochrome P450 Enzymes in Human Breast Carcinogenesis
    Francesmary Modugno
    Carmela Knoll
    Amal Kanbour-Shakir
    Marjorie Romkes
    Breast Cancer Research and Treatment, 2003, 82 : 191 - 197